Vincenzo M.
- Country
- Italy
- Department
- Medicine - Division of Nephrology
Research Overview
- Evaluation of Corticosteroids, Dapagliflozin, and RASBs on Proteinuria in IgA Nephropathy Patients with Active and Chronic Renal Lesions
- Evaluation of Long-term Safety and Efficacy of Deucrictibant Extended-Release Tablets for Prophylactic Management of Hereditary Angioedema in Adolescents and Adults
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial of Deucrictibant XR for Prophylaxis of Angioedema Attacks in Hereditary Angioedema Patients
Data & Insights
Has run more than one trial at 22 of 82 partner sites.
Specializations
Nephrology Research
Specializes in investigating therapeutic approaches for IgA nephropathy (IgAN), focusing on targeted treatments based on kidney biopsy findings. Explores innovative therapeutic combinations including corticosteroid therapy and RAS blockers for managing renal conditions.
- Kidney Biopsy-Based Treatment Strategies
- Proteinuria Management
- Early Intervention Protocols
Investigates the application of SGLT2 inhibitors in treating chronic renal lesions, particularly exploring their potential as alternatives to conventional therapies.
Rare Disease Management
Conducts research in the treatment of Hereditary Angioedema (HAE), particularly focusing on long-term prophylactic approaches. Evaluates novel therapeutic agents for preventing HAE attacks in diverse patient populations.
- Prophylactic Treatment Development
- Extended-Release Formulations
- Long-term Safety Assessment
Explores the therapeutic potential of deucrictibant in managing hereditary angioedema, with particular attention to extended-release formulations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.